2025. Anti-TNF Treatment In Refractory Sarcoidosis; Therapeutic Impacts Of Adalimumab And Infliximab. The Review of Diabetic Studies . (Apr. 2025), 120–130. DOI:https://doi.org/10.70082/crmrkr78.